In cases of overexpression (due to gene amplification as in HER2-positive BC), tyrosine-1248 (pHER2Y1248) is the most potent site because it is constitutively activated as a consequence of HER2 homodimerization. The gene discussed is ERBB2; the disease is breast cancer.